Purchase Order HT942523P0096
- Not listed
- The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
- This federal contract award is for the delivery of controls, reagents, and consumables from Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $202,026.53 firm-fixed-price delivery order was awarded by the Defense Health Agency (DHA) and is not set aside for any special designations. Qiagen is an experienced federal contractor, holding multiple indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) with agencies such as the Department of...
- This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Qiagen, LLC for a reagent kit needed to sequence libraries. The contract has a ceiling value of $22,607.27 and a completion date of September 30, 2024. Qiagen is a division of the international provider Qiagen N.V. and has extensive experience supporting federal agencies' biomedical research, public health, and healthcare programs through past prime and subcontract awards....
- This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
- This federal contract award is for Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V., to provide 6 DNeasy 96 Plant Kits to a U.S. government agency for $8,970.78. The contract has a firm-fixed price and an ultimate completion date of July 27, 2015. Qiagen is an experienced federal contractor, holding multiple indefinite delivery vehicles (IDVs) with agencies such as the Department of Veterans Affairs, Defense Health Agency, and Federal Bureau of Investigation to...
- This federal contract award to Qiagen Sciences LLC, a foreign-owned for-profit organization, is for the delivery of Deoxyribonucleic Acid (DNA) Organ Transplant Kits and EZ1 & 2 DNA Blood 350 μL Kits. The $11,310.40 Firm Fixed Price contract was awarded on December 27, 2023 by the Defense Health Agency, a defense agency, with a completion date of August 19, 2024. The contract was not set aside for any specific business category. Qiagen Sciences LLC is an established federal contractor,...
- This federal contract award from the Defense Health Agency (DHA) is for the procurement of EZ1 DNA BLOOD 350 UL KIT TO PURIFY BLOOD, a product offered by Qiagen, LLC, a foreign-owned, for-profit manufacturer. The $39,770.00 firm fixed-price purchase order does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has an extensive portfolio of federal contract awards and grant activities supporting biomedical research, public...
- This federal contract award to Qiagen, LLC, a subsidiary of the international provider Qiagen N.V., has a ceiling value of $180,000.00. The award is for "OTHER FUNCTIONS" and was made on December 29, 2016, with an ultimate completion date of December 28, 2019. The contract is a Firm Fixed Price Purchase Order without a Set-Aside designation. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
- This contract award to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics products, is for the purchase of 10,196 DNeasy UltraClean 96 Microbial Kits. The $78,505.00 Firm Fixed Price contract is a BPA Call and was awarded on June 13, 2025 by the Defense Health Agency, a defense agency. The contract has an ultimate completion date of July 31, 2025 and does not utilize any set-aside designations. Qiagen, LLC is the prime contractor and has been awarded several other...
- This federal contract award was made by a civilian federal agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the purchase of scientific consumables, such as DNA/RNA extraction kits, next-generation sequencing equipment, and bioinformatics software, with a ceiling value of $6,162.64. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Qiagen's ability to compete effectively in the federal...
This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular biology products to support the agency's biomedical research and healthcare programs. Qiagen, with its extensive experience supplying a range of sample preparation technologies, next-generation sequencing equipment, and bioinformatics software to various federal agencies, was awarded this firm fixed-price purchase order contract with a performance period ending on September 16, 2023. In addition to this specific award, Qiagen holds several larger indefinite delivery vehicles (IDVs), such as blanket purchase agreements and IDIQ contracts, with agencies like the Department of Veterans Affairs, Defense Health Agency, and Federal Bureau of Investigation. These IDVs enable efficient recurring procurement of Qiagen's specialized molecular diagnostics products and services across the government.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Targeted DNA Panels and Kits | HT942523R0086 | Defense Health Agency | Solicitation 1/1 | 7/11/23, 9:55 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.8k | 8/30/23 |